PKC-theta inhibitors (Lilly)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePKC-theta inhibitors (Lilly)
Drug Alias Nameprotein kinase C-theta inhibitors (Lilly)LSN-2354727LSN-2332764
ClassificationSmall molecules
Mechanisms of ActionInterleukin-2 inhibitorsImmunosuppressantsProtein kinase C theta inhibitors
TargetsProtein kinase C thetaInterleukin-2
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A